Patent 7683072 was granted and assigned to Purdue Pharma on March, 2010 by the United States Patent and Trademark Office.
In certain embodiments the invention is directed to a process for preparing an oxycodone hydrochloride composition having less than 25 ppm of 14-hydroxycodeinone.